Visilizumab (Anti-CD3)
Visilizumab (Anti-CD3) is a humanized, non-Fc receptor (FcR)-binding IgG2 monoclonal antibody (MoAb) directed against CD3 with potential immunosuppressive activity. Visilizumab has the potential to be used for ulcerative colitis and Crohn's disease research. MW : 144.62 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2816 |
| Sku # | A2816-1mg*25 |
| Pricing | 1mg*25, $5070.00 |